Bruno Pougault/LinkedIn
Jul 16, 2026, 12:07
Bruno Pougault: ISTH 2026 Paris Highlights – Looking Ahead
Bruno Pougault, Global Marketing Hemostasis Product Manager at HORIBA, shared a post on LinkedIn:
“ISTH 2026 Paris Highlights: Looking Ahead
What an inspiring week at ISTH 2026 in Paris!
- Novel hemostasis therapies continue to improve efficacy while aiming to reduce bleeding risk.
- Advances in gene and RNA-based approaches are opening new perspectives for rare bleeding disorders.
- Next-generation diagnostics are enabling earlier and more precise patient stratification.
- AI-powered analytics and digital tools are accelerating clinical decision-making and personalized care.
- Global collaborations are strengthening access to innovation and evidence-based medicine.
- Emerging data in thrombosis and hemostasis are reshaping the future of patient management.
- Paris once again proved to be a unique crossroads of art, culture, and science, providing an inspiring setting for innovation and exchange.
- A sincere thank you to the ISTH organizers, speakers, partners, and participants for an outstanding congress.
Goodbye Paris, and thank you for the unforgettable moments, scientific excellence, and international connections.
Let’s keep looking to the future and transforming innovation into better outcomes for”

Other posts featuring Bruno Pougault on Hemostasis Today.
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session
-
Aug 30, 2026, 17:02David McGlasson: A 2020 Article Reaches 8,000 Reads
-
Aug 30, 2026, 16:18Tushar Namdeo: Platelets in Different Diseases
-
Aug 30, 2026, 16:16Fatima Zafar: Anaemia – Why This “Common” Condition Should Never Be Ignored
-
Aug 30, 2026, 16:13Umeshkumar C.: Evaluating Scoring Systems and Biomarkers for DIC in Critically Ill Patients